Medicis Pharmaceutical Corp. (MRX) Tops Q4 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Wall St slips as Middle East uncertainty lifts oil; Trump-Xi talks in focus
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Plug Power COO resigns to join another company
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Wall Street ends down as oil prices, Treasury yields rise
Marex Group PLC (MRX) PT Raised to $42 at Jefferies
March 10, 2025 4:52 AM EDTJefferies analyst Daniel Fannon raised the price target on Marex Group PLC (NASDAQ: MRX) to $42.00 (from $38.00) while maintaining a Buy rating.
The analyst comments "Following 4Q24 results, our EPS estimate for 1Q25 remains unchanged at $0.83 and our FY25 EPS estimate increases from $3.00 to $3.11. These... More
